1. Home
  2. STIM vs JHS Comparison

STIM vs JHS Comparison

Compare STIM & JHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neuronetics Inc.

STIM

Neuronetics Inc.

HOLD

Current Price

$2.92

Market Cap

120.4M

Sector

Health Care

ML Signal

HOLD

Logo John Hancock Income Securities Trust

JHS

John Hancock Income Securities Trust

HOLD

Current Price

$10.53

Market Cap

126.9M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
STIM
JHS
Founded
2003
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Finance Companies
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
120.4M
126.9M
IPO Year
2018
1994

Fundamental Metrics

Financial Performance
Metric
STIM
JHS
Price
$2.92
$10.53
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$3.00
N/A
AVG Volume (30 Days)
1.3M
13.2K
Earning Date
05-05-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
57.25
N/A
EPS
N/A
N/A
Revenue
$52,776,000.00
N/A
Revenue This Year
$11.10
N/A
Revenue Next Year
$11.92
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.80
$10.39
52 Week High
$3.44
$12.09

Technical Indicators

Market Signals
Indicator
STIM
JHS
Relative Strength Index (RSI) 54.40 31.97
Support Level $1.20 N/A
Resistance Level N/A $11.01
Average True Range (ATR) 0.22 0.07
MACD -0.04 -0.04
Stochastic Oscillator 45.16 24.56

Price Performance

Historical Comparison
STIM
JHS

About STIM Neuronetics Inc.

Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.

About JHS John Hancock Income Securities Trust

John Hancock Income Securities Trust is a United States-based closed-end diversified management investment company. Its main objective is to generate a high level of current income consistent with prudent investment risk. The fund invests its net assets (plus borrowings for investment purposes) in income securities, consisting of marketable corporate debt securities, governmental obligations, and cash and commercial paper. A majority of its net assets are invested in debt securities that are rated, at the time of acquisition, investment-grade or in unrated securities determined by the Fund's investment advisor or subadvisor to be of comparable credit quality.

Share on Social Networks: